Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1070

1.

Fusaramin, an antimitochondrial compound produced by Fusarium sp., discovered using multidrug-sensitive Saccharomyces cerevisiae.

Sakai K, Unten Y, Iwatsuki M, Matsuo H, Fukasawa W, Hirose T, Chinen T, Nonaka K, Nakashima T, Sunazuka T, Usui T, Murai M, Miyoshi H, Asami Y, Ōmura S, Shiomi K.

J Antibiot (Tokyo). 2019 Jun 17. doi: 10.1038/s41429-019-0197-5. [Epub ahead of print]

PMID:
31204387
2.

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.

Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi M Ag R, Hatanaka KC, Terauchi Y, Atsumi T.

Metabolism. 2019 Jun 13. pii: S0026-0495(19)30115-5. doi: 10.1016/j.metabol.2019.06.006. [Epub ahead of print]

PMID:
31202833
3.

Lineage tracing and targeting of IL17RB+ tuft cell-like human colorectal cancer stem cells.

Goto N, Fukuda A, Yamaga Y, Yoshikawa T, Maruno T, Maekawa H, Inamoto S, Kawada K, Sakai Y, Miyoshi H, Taketo MM, Chiba T, Seno H.

Proc Natl Acad Sci U S A. 2019 Jun 10. pii: 201900251. doi: 10.1073/pnas.1900251116. [Epub ahead of print]

PMID:
31182574
4.

A Case of Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis.

Miyoshi H, Kano M, Kobayashi S, Ito T, Masuda M, Mitsuyama T, Nakayama S, Ikeura T, Shimatani M, Uchida K, Takaoka M, Okazaki K.

Intern Med. 2019 Jun 7. doi: 10.2169/internalmedicine.2689-19. [Epub ahead of print]

5.

Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.

Kurita D, Miyoshi H, Ichikawa A, Kato K, Imaizumi Y, Seki R, Sato K, Sasaki Y, Kawamoto K, Shimono J, Yamada K, Muto R, Kizaki M, Nagafuji K, Tamaru JI, Tokuhira M, Ohshima K.

Am J Surg Pathol. 2019 Jul;43(7):869-884. doi: 10.1097/PAS.0000000000001271.

PMID:
31116708
6.

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.

Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H, Zhao L, Ochi Y, Takeuchi Y, Takeda J, Ueno H, Kogure Y, Shiozawa Y, Kakiuchi N, Yoshizato T, Nakagawa MM, Nanya Y, Yoshida K, Makishima H, Sanada M, Sakata-Yanagimoto M, Chiba S, Matsuoka R, Noguchi M, Hiramoto N, Ishikawa T, Kitagawa J, Nakamura N, Tsurumi H, Miyazaki T, Kito Y, Miyano S, Shimoda K, Takeuchi K, Ohshima K, Yoshino T, Ogawa S, Kataoka K.

Leukemia. 2019 May 15. doi: 10.1038/s41375-019-0473-1. [Epub ahead of print]

PMID:
31092896
7.

Visualization of spatiotemporal dynamics of human glioma stem cell invasion.

Tamura R, Miyoshi H, Sampetrean O, Shinozaki M, Morimoto Y, Iwasawa C, Fukaya R, Mine Y, Masuda H, Maruyama T, Narita M, Saya H, Yoshida K, Okano H, Toda M.

Mol Brain. 2019 May 6;12(1):45. doi: 10.1186/s13041-019-0462-3.

8.

Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y.

J Diabetes Investig. 2019 Apr 26. doi: 10.1111/jdi.13064. [Epub ahead of print]

9.

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Kawano N, Yoshida N, Kawano S, Arakawa F, Miyoshi H, Yamada K, Nakashima K, Yoshida S, Kuriyama T, Tochigi T, Nakaike T, Shimokawa T, Yamashita K, Marutsuka K, Mashiba K, Kikuchi I, Ohshima K.

Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2513-18. [Epub ahead of print]

10.

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.

Komaki S, Sugita Y, Furuta T, Yamada K, Moritsubo M, Abe H, Akiba J, Miyagi N, Nakamura H, Miyoshi H, Ohshima K, Morioka M.

J Neuropathol Exp Neurol. 2019 May 1;78(5):389-397. doi: 10.1093/jnen/nly124.

11.

Usefulness of Preoperative 18F-FDG PET/CT for Patients with Thymic Epithelial Tumors.

Ishibashi M, Tanabe Y, Yunaga H, Miyoshi H, Miwa K, Nakamura H, Fujii S, Ogawa T.

Yonago Acta Med. 2019 Mar 28;62(1):146-152. eCollection 2019 Mar.

12.

Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.

Satou A, Tabata T, Miyoshi H, Kohno K, Suzuki Y, Yamashita D, Shimada K, Kawasaki T, Sato Y, Yoshino T, Ohshima K, Takahara T, Tsuzuki T, Nakamura S.

Mod Pathol. 2019 Apr 5. doi: 10.1038/s41379-019-0264-2. [Epub ahead of print]

PMID:
30952973
13.

Anaplastic large cell lymphoma, with 1,25(OH)2D3-mediated hypercalcemia: A case report.

Mitobe M, Kawamoto K, Suzuki T, Kiryu M, Nanba A, Suwabe T, Tanaka T, Fuse K, Shibasaki Y, Masuko M, Miyoshi H, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2019;59(1):22-28. doi: 10.3960/jslrt.18033.

14.

Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy.

Tanaka Y, Ishihara M, Miyoshi H, Hashimoto A, Shinzato I, Ohshima K.

J Clin Exp Hematop. 2019;59(1):17-21. doi: 10.3960/jslrt.18020.

15.

Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment.

Nomoto H, Kameda H, Nakamura A, Tsuchida K, Nagai S, Atsumi T, Miyoshi H.

Front Endocrinol (Lausanne). 2019 Mar 1;10:131. doi: 10.3389/fendo.2019.00131. eCollection 2019.

16.

Comprehensive evaluation of ubiquitous promoters suitable for the generation of transgenic cynomolgus monkeys†.

Seita Y, Tsukiyama T, Azami T, Kobayashi K, Iwatani C, Tsuchiya H, Nakaya M, Tanabe H, Hitoshi S, Miyoshi H, Nakamura S, Kawauchi A, Ema M.

Biol Reprod. 2019 Jun 1;100(6):1440-1452. doi: 10.1093/biolre/ioz040.

PMID:
30869744
17.

Antibiotic Korormicin A Kills Bacteria by Producing Reactive Oxygen Species.

Maynard A, Butler NL, Ito T, da Silva AJ, Murai M, Chen T, Koffas MAG, Miyoshi H, Barquera B.

J Bacteriol. 2019 May 8;201(11). pii: e00718-18. doi: 10.1128/JB.00718-18. Print 2019 Jun 1.

PMID:
30858300
18.

Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I.

Banba A, Tsuji A, Kimura H, Murai M, Miyoshi H.

J Biol Chem. 2019 Apr 19;294(16):6550-6561. doi: 10.1074/jbc.RA119.007687. Epub 2019 Mar 1.

PMID:
30824536
19.

9,10-Dihydro- as-indacenodithiophenes: Isomers with an as-Indacene Core.

Miyoshi H, Nabe A, Chatterjee S, Tobe Y.

J Org Chem. 2019 Apr 5;84(7):3927-3939. doi: 10.1021/acs.joc.8b03049. Epub 2019 Mar 12.

PMID:
30821459
20.

Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells.

Iwasawa C, Tamura R, Sugiura Y, Suzuki S, Kuzumaki N, Narita M, Suematsu M, Nakamura M, Yoshida K, Toda M, Okano H, Miyoshi H.

Int J Mol Sci. 2019 Feb 14;20(4). pii: E810. doi: 10.3390/ijms20040810.

21.

Expansion of mouse hematopoietic stem/progenitor cells in three-dimensional cocultures on growth-suppressed stromal cell layer.

Miyoshi H, Sato C, Shimizu Y, Morita M.

Int J Artif Organs. 2019 Feb 12:391398819827596. doi: 10.1177/0391398819827596. [Epub ahead of print]

PMID:
30744504
22.

Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.

Shibayama Y, Kameda H, Ota S, Tsuchida K, Cho KY, Nakamura A, Miyoshi H, Atsumi T.

J Diabetes Investig. 2019 Feb 9. doi: 10.1111/jdi.13022. [Epub ahead of print]

23.

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Shimono J, Miyoshi H, Arakawa F, Yamada K, Sugio T, Miyawaki K, Eto T, Miyagishima T, Kato K, Nagafuji K, Akashi K, Teshima T, Ohshima K.

Ann Hematol. 2019 May;98(5):1197-1207. doi: 10.1007/s00277-019-03628-8. Epub 2019 Feb 7.

PMID:
30729289
24.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jan 25. doi: 10.1038/s41375-019-0380-5. [Epub ahead of print]

PMID:
30683910
25.

Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells.

Yamaura T, Miyoshi H, Maekawa H, Morimoto T, Yamamoto T, Kakizaki F, Higasa K, Kawada K, Matsuda F, Sakai Y, Taketo MM.

Oncotarget. 2018 Dec 25;9(101):37534-37548. doi: 10.18632/oncotarget.26495. eCollection 2018 Dec 25.

26.

Pentenediol-Type Compounds Specifically Bind to Voltage-Dependent Anion Channel 1 in Saccharomyces cerevisiae Mitochondria.

Unten Y, Murai M, Yamamoto T, Watanabe A, Ichimaru N, Aburaya S, Aoki W, Shinohara Y, Miyoshi H.

Biochemistry. 2019 Feb 26;58(8):1141-1154. doi: 10.1021/acs.biochem.8b01209. Epub 2019 Feb 4.

PMID:
30657320
27.

Arid1a is essential for intestinal stem cells through Sox9 regulation.

Hiramatsu Y, Fukuda A, Ogawa S, Goto N, Ikuta K, Tsuda M, Matsumoto Y, Kimura Y, Yoshioka T, Takada Y, Maruno T, Hanyu Y, Tsuruyama T, Wang Z, Akiyama H, Takaishi S, Miyoshi H, Taketo MM, Chiba T, Seno H.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1704-1713. doi: 10.1073/pnas.1804858116. Epub 2019 Jan 11.

PMID:
30635419
28.

Human leukocyte antigen class II expression is a good prognostic factor of adult T-cell leukemia/lymphoma.

Takeuchi M, Miyoshi H, Asano N, Yoshida N, Yamada K, Yanagida E, Moritsubo M, Nakata M, Umeno T, Suzuki T, Komaki S, Muta H, Furuta T, Seto M, Ohshima K.

Haematologica. 2019 Jan 10. pii: haematol.2018.205567. doi: 10.3324/haematol.2018.205567. [Epub ahead of print]

29.

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.

Kawagishi N, Suda G, Nakamura A, Kimura M, Maehara O, Suzuki K, Nakamura A, Ohara M, Izumi T, Umemura M, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Kudo Y, Nishida M, Miyoshi H, Sakamoto N.

PLoS One. 2018 Dec 21;13(12):e0209615. doi: 10.1371/journal.pone.0209615. eCollection 2018.

30.

The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus.

Niwa H, Takahashi K, Dannoura M, Oomori K, Miyoshi A, Inada T, Miyoshi H.

J Atheroscler Thromb. 2018 Nov 28. doi: 10.5551/jat.45674. [Epub ahead of print]

31.

Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.

Kojima K, Miyoshi H, Nagoshi N, Kohyama J, Itakura G, Kawabata S, Ozaki M, Iida T, Sugai K, Ito S, Fukuzawa R, Yasutake K, Renault-Mihara F, Shibata S, Matsumoto M, Nakamura M, Okano H.

Stem Cells Transl Med. 2019 Mar;8(3):260-270. doi: 10.1002/sctm.18-0096. Epub 2018 Nov 28.

32.

Postoperative thoracic and low back pain following endovascular aortic repair associated with stenting location.

Miyoshi H, Hamada H, Nakamura R, Kondo T, Yasuda T, Saeki N, Kawamoto M.

J Anesth. 2019 Feb;33(1):75-79. doi: 10.1007/s00540-018-2586-5. Epub 2018 Nov 24.

PMID:
30470896
33.

Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.

Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, Takiguchi M, Kassai Y, Imai E, Yasui Y, Kawai Y, Zhang R, Uemura Y, Miyoshi H, Nakanishi M, Watanabe A, Hayashi A, Kawana K, Fujii T, Nakatsura T, Kaneko S.

Cell Stem Cell. 2018 Dec 6;23(6):850-858.e4. doi: 10.1016/j.stem.2018.10.005. Epub 2018 Nov 15.

PMID:
30449714
34.

Exploring the quinone/inhibitor-binding pocket in mitochondrial respiratory complex I by chemical biology approaches.

Uno S, Kimura H, Murai M, Miyoshi H.

J Biol Chem. 2019 Jan 11;294(2):679-696. doi: 10.1074/jbc.RA118.006056. Epub 2018 Nov 13.

PMID:
30425100
35.

Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.

Kawamoto K, Suzuki T, Kasami T, Kiryu M, Sone H, Miyoshi H, Ohshima K, Takizawa J.

Hematol Oncol. 2019 Apr;37(2):212-214. doi: 10.1002/hon.2565. Epub 2018 Nov 19. No abstract available.

PMID:
30394560
36.

Non‑invasive monitoring of cisplatin and erlotinib efficacy against lung cancer in orthotopic SCID mouse models by small animal FDG‑PET/CT and CT.

Otani T, Kondo K, Takizawa H, Kajiura K, Fujino H, Otsuka H, Miyoshi H.

Oncol Rep. 2019 Jan;41(1):447-454. doi: 10.3892/or.2018.6818. Epub 2018 Oct 24.

PMID:
30365151
37.

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Muto R, Miyoshi H, Sato K, Furuta T, Muta H, Kawamoto K, Yanagida E, Yamada K, Ohshima K.

Cancer Med. 2018 Nov;7(11):5843-5858. doi: 10.1002/cam4.1805. Epub 2018 Oct 11.

38.

Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.

Cho KY, Nakamura A, Omori K, Takase T, Miya A, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Diabetes Obes Metab. 2019 Mar;21(3):710-714. doi: 10.1111/dom.13557. Epub 2018 Nov 8.

39.

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.

Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Am J Surg Pathol. 2018 Nov;42(11):1466-1471. doi: 10.1097/PAS.0000000000000969.

40.

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.

Matsukawa T, Suto K, Miyoshi H, Oshimi K, Ohshima K, Miyagishima T.

J Clin Exp Hematop. 2018 Dec 13;58(4):184-187. doi: 10.3960/jslrt.18027. Epub 2018 Oct 10. No abstract available.

41.

Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.

Tamura S, Kawamoto K, Miyoshi H, Suzuki T, Katagiri T, Kasami T, Nemoto H, Miyakoshi S, Kobayashi H, Shibasaki Y, Masuko M, Takeuchi K, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2018 Dec 13;58(4):161-165. doi: 10.3960/jslrt.18015. Epub 2018 Oct 10.

42.

Synchronous case of follicular lymphoma and Langerhans cell sarcoma in the same lymph node.

Shimono J, Miyoshi H, Arakawa F, Abe H, Miyagishima T, Akiba J, Teshima T, Ohshima K.

Pathol Int. 2018 Nov;68(11):614-617. doi: 10.1111/pin.12722. Epub 2018 Sep 25.

PMID:
30255584
43.

Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan.

Tsushima Y, Awai K, Shinoda G, Miyoshi H, Chosa M, Sunaya T, Endrikat J.

Jpn J Radiol. 2018 Nov;36(11):676-685. doi: 10.1007/s11604-018-0778-4. Epub 2018 Sep 19.

PMID:
30232584
44.

Fetal Membrane Inflammation Induces Preterm Birth Via Toll-Like Receptor 2 in Mice With Chronic Gingivitis.

Konishi H, Urabe S, Miyoshi H, Teraoka Y, Maki T, Furusho H, Miyauchi M, Takata T, Kudo Y, Kajioka S.

Reprod Sci. 2018 Sep 17:1933719118792097. doi: 10.1177/1933719118792097. [Epub ahead of print]

PMID:
30223727
45.

Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements.

Mitobe M, Kawamoto K, Suzuki T, Kiryu M, Tamura S, Nanba A, Suwabe T, Tanaka T, Fuse K, Shibasaki Y, Masuko M, Miyoshi H, Ohshima K, Sone H, Takizawa J.

Intern Med. 2019 Feb 15;58(4):575-580. doi: 10.2169/internalmedicine.1686-18. Epub 2018 Sep 12.

46.

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS.

Sugio T, Miyawaki K, Kato K, Sasaki K, Yamada K, Iqbal J, Miyamoto T, Ohshima K, Maeda T, Miyoshi H, Akashi K.

Blood Adv. 2018 Sep 11;2(17):2242-2252. doi: 10.1182/bloodadvances.2018018754.

47.

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.

Takahashi K, Cho KY, Nakamura A, Miya A, Miyoshi A, Yamamoto C, Nomoto H, Niwa H, Takahashi K, Manda N, Kurihara Y, Aoki S, Ito YM, Atsumi T, Miyoshi H.

J Diabetes Investig. 2019 Mar;10(2):429-438. doi: 10.1111/jdi.12913. Epub 2018 Sep 26.

48.

Clinicopathological and immunohistochemical analysis of autoimmune regulator expression in patients with osteosarcoma.

Matsuda K, Miyoshi H, Moritsubo M, Hiraoka K, Hamada T, Shiba N, Ohshima K.

Clin Exp Metastasis. 2018 Oct;35(7):641-648. doi: 10.1007/s10585-018-9928-4. Epub 2018 Aug 18.

PMID:
30121939
49.

Tbx6 Induces Nascent Mesoderm from Pluripotent Stem Cells and Temporally Controls Cardiac versus Somite Lineage Diversification.

Sadahiro T, Isomi M, Muraoka N, Kojima H, Haginiwa S, Kurotsu S, Tamura F, Tani H, Tohyama S, Fujita J, Miyoshi H, Kawamura Y, Goshima N, Iwasaki YW, Murano K, Saito K, Oda M, Andersen P, Kwon C, Uosaki H, Nishizono H, Fukuda K, Ieda M.

Cell Stem Cell. 2018 Sep 6;23(3):382-395.e5. doi: 10.1016/j.stem.2018.07.001. Epub 2018 Aug 9.

PMID:
30100166
50.

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.

Takase T, Nakamura A, Yamamoto C, Nomoto H, Miya A, Dannoura M, Cho KY, Kurihara Y, Manda N, Aoki S, Atsumi T, Miyoshi H.

J Diabetes Investig. 2019 May;10(3):699-705. doi: 10.1111/jdi.12906. Epub 2018 Sep 19.

Supplemental Content

Loading ...
Support Center